Search Results 1981-1990 of 17177 for rheumatoid arthritis

1. RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy - Mayo Clinic

   ... Rheumatology classification criteria * Diagnosis of DM, ASyS, IMNM based on the presence of serum myositis-specific antibodies * Evidence of active disease ...

2. A Study to Evaluate Preoperative Oral Microbiota-Based Investigational New Drug to Target Immune Response in Patients with Operable Stage I-III Breast Cancer - Mayo Clinic

   Estrogen receptor (ER) and/or progesterone receptor (PR) positive ≥ 10%, and no human epidermal growth factor receptor 2 (HER2) amplification or overexpression ...

3. Publications - Todd A. Kellogg, M.D. - Mayo Clinic

   Hypoxia-inducible factor 1a stabilization restores epigenetic control of nitric oxide synthase 1 expression and reverses gastroparesis in female diabetic mice.

4. Shoulder Disorder Clinical Trials - Mayo Clinic Research

   ... arthritis. . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo Clinic · Employees · Site Map · About This Site. Legal Conditions and ...

5. Molecular Mechanisms of Tumorigenesis: Verline Justilien - Research Projects

   Oncogenic Ect2 signaling in cancer. Epithelial cell transforming sequence 2 (Ect2) is a guanine nucleotide exchange factor that activates the Rho family of ...

6. Back pain - Doctors and departments - Mayo Clinic

   ... Arthritis, Herniated disk, Neck pain, Cervical spondylosis, Amyotrophic lateral sclerosis, Myelopathy, Paraparesis, Dystonia, Charcot-Marie-Tooth disease ...

7. A Study of Gemcitabine-Cisplatin Chemotherapy plus Necitumumab in the First-Line Treatment of Patients with Lung Cancer - Mayo Clinic

   ... factor receptor (EGFR), vascular endothelial growth factor (VEGF), or VEGF receptor; Previous chemotherapy for NSCLC; Major surgery or received any ...

8. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study - Mayo Clinic

   ... factor Xa inhibitor betrixaban, or platelet inhibitors (e.g., clopidogrel). - Participants must not require anticoagulants except for the following ...

9. Recurrent Breast Cancer Clinical Trials - Mayo Clinic Research

   ... factor receptor-2 [HER2]), how often genetic mutations occur, and why the cancer might or might not respond to monoclonal antibody therapy, such as ...

10. Joint Replacement Revisions Clinical Trials - Mayo Clinic Research

    One factor that may cause failure of a total hip arthroplasty is an elevated level of these ions around the hip. Comparative Effectiveness of Pulmonary ...